Newsroom | 1755 results

CAMBRIDGE, Mass. & MONTREAL--(BUSINESS WIRE)--Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a leading clinical-stage precision oncology company, today announced the acceptance of two abstracts for mini-oral presentation and the acceptance of four abstracts for poster presentation at the American Association for Cancer Research (AACR) Annual Meeting, taking place April 25-30, 2025, in Chicago, Illinois. Mini-Oral Presentation Details: Title: Efficacy and safety of the comb...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--InsideTracker, a leader in data-driven health technology, is pleased to introduce Terra, a first-of-its-kind virtual coach that enables its members to dive deep into their own body. Terra builds on the success of Ask InsideTracker, a native AI tool released last year and now one of the platform’s most popular features. With this major version update, Terra becomes a personalized health coach with the ability to access information and offer recommendations typi...

DENVER--(BUSINESS WIRE)--Illinoisans now have easy access to user friendly enhanced health stations through a collaboration between Modivcare Inc. (the “Company” or “Modivcare”) (Nasdaq: MODV), a healthcare services company integrating technology into personalized care experiences, focused on improving health outcomes, and Aetna Better Health® of Illinois, a CVS Health® company. The Modivcare Higi Stations offer self-service health information and digital navigation, as well as functionality to...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vizgen, Inc., the life sciences company revolutionizing spatial genomics and proteomics research and driving innovation in spatial multi-omics, today announced the broad global commercial availability of MERFISH 2.0™, a next-generation spatial transcriptomics chemistry designed to drive breakthroughs in foundational biological research. The company also announced the expansion of fully configurable OmniVUE™ spatial proteomics panels with validated biomarkers a...

SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, announced today the return of Dexcom U – its one-of-a-kind Name, Image and Likeness program exclusively for college athletes with diabetes – for an expanded fourth season, including the first-ever nationwide open call for passionate and inspiring college athletes to join its roster. Now through May 23, athletes, coaches, friends and family members can nominate candidates through an online submissio...

SUNNYVALE, Calif.--(BUSINESS WIRE)--Jumio, the leading provider of automated, AI-driven biometric identity verification, risk signals and compliance solutions, today announced general availability of Cross-Transaction Risk, which helps businesses proactively detect fraud by connecting identity elements across the Jumio network. A key capability within the Jumio Identity Reputation suite, Cross-Transaction Risk enables organizations to strike the ideal balance between advanced fraud detection, s...

悉尼--(BUSINESS WIRE)--(美国商业资讯)-- Novotech（诺为泰）作为一家可提供全方位服务的国际性临床研究组织 (CRO) 和科学咨询公司，致力于携手生物科技公司以及中小型制药公司，共同推进药物开发。近日，诺为泰正式发布了关于特发性肺纤维化 (IPF) 全球临床试验领域的深度洞察报告。该报告为生物技术和制药公司应对IPF临床研究及药物开发的复杂性问题，提供了重要的战略见解和全面分析。 推进IPF临床研究：全球视角 特发性肺纤维化 (IPF) 是一种慢性、进行性肺部疾病，其主要特征是肺组织的瘢痕化，导致呼吸功能逐渐减退，好发于60至70岁之间的老年人群。诺为泰近期发布的报告显示，自2020年以来，全球启动了800多项行业资助的IPF临床试验，这表明生物技术及制药行业的研究势头强劲，对日益加重的IPF疾病负担的解决愈发重视。 主要亮点： 全球临床试验概况：亚太地区的IPF临床试验占比较高，达44%，这主要得益于中国大陆开展的大量临床试验活动。其次是北美地区，占比23%，美国在该地区的临床试验活动中占据重要地位；欧洲占比21%，该地区的临床试验活动主要集中于英国和德国...

雪梨--(BUSINESS WIRE)--(美國商業資訊)-- Novotech作為一家可提供全方位服務的國際性受託研究機構 (CRO) 和科學諮詢公司，致力於攜手生物科技公司以及中小型製藥公司，共同推動藥物開發。近日，Novotech發佈了關於特發性肺纖維化 (IPF) 全球臨床試驗領域的深度洞察報告。這份報告為生物技術和製藥公司因應IPF臨床研究及藥物開發的複雜性問題，提供了重要的策略見解和全面分析。 推動IPF臨床研究：全球視角觀察 特發性肺纖維化 (IPF) 是一種慢性、漸進性肺部疾病，其主要特徵是肺組織的纖維化，導致呼吸功能逐漸減退，好發於60至70歲之間的老年人群。Novotech近期發佈的報告顯示，自2020年以來，全球展開了800多項業界委託的IPF臨床試驗，這反映生物技術及製藥業的研究勢頭強勁，對日益加重的IPF疾病負擔的解決愈發重視。 主要重點： 全球臨床試驗概況：亞太地區的IPF臨床試驗所佔比例較高，達44%，這主要得益於中國大陸展開的大量臨床試驗活動。其次是北美地區，佔23%，美國在該地區的臨床試驗活動中佔據重要地位；歐洲佔21%，該地區的臨床試驗活動主要集中於...

SYDNEY--(BUSINESS WIRE)--Novotech, a globally recognized CRO has released an in-depth report on the global clinical trial landscape for Idiopathic Pulmonary Fibrosis....

SAN FRANCISCO--(BUSINESS WIRE)--Trellis Health, a digital health platform designed to empower women with personalized, proactive care, today emerged from stealth. The company is launching with $1.8M in pre-seed funding from Palette Ventures, Swizzle Ventures, NEXTBLUE, Suncoast Ventures, and Sundial Foundation, along with high-profile healthcare individuals, including Care.com founder Sheila Marcelo, the co-founders of Flo Health, Yuri Gurski and Andrei Kouzel, Mike Prytkov - the founder and CE...